Combatting COVID-19

Hear from UBC experts, learn more about work on the frontlines, and discover the latest research helping to combat the global outbreak.

Pilot clinical trial in China to test UBC researcher’s findings as a targeted therapy for COVID-19

APN01, a drug made by Apeiron Biologics and developed based on the work of UBC’s Josef Penninger, is already shown to block viral spread in SARS.

UBC experts answer coronavirus (COVID-19) questions

Faculty members share their expertise in specialties from pediatrics to psychiatry.